Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil E Kay

Showing results (221-230 of 325) with videos related to

Pageof 33
Sort By:
Cancer Genetics and Cytogenetics|December 16, 2010
Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) StudyNyla A Heerema, John C Byrd, Paola S Dal Cin, et al.
American Journal of Hematology|April 13, 2017
Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance studyJeremy T Larsen, Tait D Shanafelt, Jose F Leis, et al.
Leukemia|February 16, 2022
Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosisNicholas J Boddicker, Sara J Achenbach, Sameer A Parikh, et al.
Leukemia & Lymphoma|May 26, 2020
Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practiceAmber B Koehler, Nelson Leung, Timothy G Call, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemiaTait D Shanafelt, Thomas E Witzig, Stephanie R Fink, et al.
Haematologica|February 9, 2018
Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosisSameer A Parikh, Kari G Chaffee, Melissa C Larson, et al.
British Journal of Haematology|September 16, 2009
Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progressionWei Ding, Grzegorz S Nowakowski, Traci R Knox, et al.
Cancers|July 13, 2024
Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number AlterationsJ Erin Wiedmeier-Nutor, Chantal E McCabe, Daniel R O'Brien, et al.
Leukemia|March 16, 2019
KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survivalElena Vendramini, Riccardo Bomben, Federico Pozzo, et al.
Leukemia & Lymphoma|April 25, 2019
Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practicePaul J Hampel, Wei Ding, Timothy G Call, et al.
Pageof 33

Showing results (221-230 of 325) with videos related to

Sort By:
Pageof 33
Cancer Genetics and Cytogenetics|December 16, 2010
Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) StudyNyla A Heerema, John C Byrd, Paola S Dal Cin, et al.
American Journal of Hematology|April 13, 2017
Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance studyJeremy T Larsen, Tait D Shanafelt, Jose F Leis, et al.
Leukemia|February 16, 2022
Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosisNicholas J Boddicker, Sara J Achenbach, Sameer A Parikh, et al.
Leukemia & Lymphoma|May 26, 2020
Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practiceAmber B Koehler, Nelson Leung, Timothy G Call, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemiaTait D Shanafelt, Thomas E Witzig, Stephanie R Fink, et al.
Haematologica|February 9, 2018
Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosisSameer A Parikh, Kari G Chaffee, Melissa C Larson, et al.
British Journal of Haematology|September 16, 2009
Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progressionWei Ding, Grzegorz S Nowakowski, Traci R Knox, et al.
Cancers|July 13, 2024
Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number AlterationsJ Erin Wiedmeier-Nutor, Chantal E McCabe, Daniel R O'Brien, et al.
Leukemia|March 16, 2019
KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survivalElena Vendramini, Riccardo Bomben, Federico Pozzo, et al.
Leukemia & Lymphoma|April 25, 2019
Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practicePaul J Hampel, Wei Ding, Timothy G Call, et al.
Pageof 33